|
|
|
|
|
|
Found 34839 studies with search of: | United States |
Hide studies that are not seeking new volunteers.
|
|
1 | Completed | The Effects of Illnesses on HIV Levels in the Body | ||||
Condition: | HIV Infections | |||||
Intervention: | ||||||
2 | Completed | A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP | ||||
Condition: | HIV Infections | |||||
Intervention: | Drug: Zidovudine | |||||
3 | Completed | A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients | ||||
Conditions: | Herpes Simplex; HIV Infections | |||||
Interventions: | Drug: Valacyclovir hydrochloride; Drug: Acyclovir | |||||
4 | Completed | A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition | ||||
Conditions: | Anorexia; Cachexia; HIV Infections | |||||
Intervention: | Drug: Megestrol acetate | |||||
5 | Active, not recruiting | Diagnostic Study of Patients With Stage I Testicular Cancer | ||||
Condition: | Testicular Germ Cell Tumor | |||||
Interventions: | Procedure: immunohistochemistry staining method; Procedure: laboratory biomarker analysis; Procedure: radionuclide imaging | |||||
6 | Active, not recruiting | Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial | ||||
Conditions: | Breast Cancer; Cardiac Toxicity | |||||
Intervention: | Procedure: management of therapy complications | |||||
7 | Completed | Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer | ||||
Condition: | Lung Cancer | |||||
Interventions: | Drug: docetaxel; Drug: irinotecan hydrochloride | |||||
8 | Completed | Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy | ||||
Conditions: | Anemia; Breast Cancer; Chronic Myeloproliferative Disorders; Drug/Agent Toxicity by Tissue/Organ; Leukemia; Lung Cancer; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Precancerous/Nonmalignant Condition; Quality of Life; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific | |||||
Interventions: | Drug: epoetin alfa; Procedure: quality-of-life assessment | |||||
9 | Active, not recruiting | Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia | ||||
Condition: | Leukemia | |||||
Interventions: | Drug: asparaginase; Drug: cyclophosphamide; Drug: cytarabine; Drug: daunorubicin hydrochloride; Drug: filgrastim; Drug: leucovorin calcium; Drug: mercaptopurine; Drug: methotrexate; Drug: prednisone; Drug: vincristine sulfate | |||||
10 | Recruiting | Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia | ||||
Conditions: | Hematologic Diseases; Anemia, Sickle Cell | |||||
Intervention: | Drug: Hydroxyurea | |||||
11 | Completed | A Multi-Site Study of Strategies for Implementing Schizophrenia Guidelines | ||||
Condition: | Schizophrenia | |||||
Intervention: | Behavioral: Test strategy for implementation guideline | |||||
12 | Completed | Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia | ||||
Condition: | Lymphoma | |||||
Interventions: | Drug: fludarabine phosphate; Drug: rituximab | |||||
13 | Completed | TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB | ||||
Conditions: | HIV Infections; Tuberculosis | |||||
Interventions: | Drug: Nelfinavir; Drug: Rifabutin | |||||
14 | Completed | Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis | ||||
Condition: | Multiple Sclerosis, Relapsing-Remitting | |||||
Intervention: | Drug: Natalizumab | |||||
15 | Active, not recruiting | Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma | ||||
Condition: | Multiple Myeloma and Plasma Cell Neoplasm | |||||
Interventions: | Drug: cyclophosphamide; Drug: filgrastim; Drug: fludarabine phosphate; Drug: melphalan; Drug: methotrexate; Drug: tacrolimus; Drug: therapeutic allogeneic lymphocytes; Procedure: peripheral blood stem cell transplantation | |||||
16 | Completed | EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer | ||||
Conditions: | Ovarian Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms | |||||
Intervention: | Drug: epothilone b | |||||
17 | Completed | Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma | ||||
Condition: | Malignant Melanoma | |||||
Intervention: | Drug: HSPPC-96 or Oncophage | |||||
18 | Active, not recruiting | Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-Versus-Host Disease | ||||
Condition: | Graft-Versus-Host Disease | |||||
Interventions: | Drug: Methoxsalen; Procedure: Extracorporeal Photopheresis | |||||
19 | Active, not recruiting | Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction | ||||
Conditions: | Lymphoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific | |||||
Intervention: | Drug: ixabepilone | |||||
20 | Completed | Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma | ||||
Condition: | Neuroblastoma | |||||
Interventions: | Drug: cisplatin; Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: filgrastim; Drug: isotretinoin; Drug: melphalan; Drug: topotecan hydrochloride; Drug: vincristine sulfate; Procedure: conventional surgery; Procedure: peripheral blood stem cell transplantation; Procedure: radiation therapy | |||||
21 | Completed | A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies. | ||||
Condition: | Breast Neoplasms | |||||
Intervention: | Drug: SU011248 | |||||
22 | Active, not recruiting | A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical Care | ||||
Condition: | Carcinoma, Hepatocellular | |||||
Intervention: | Drug: DENSPM (diethylnorspermine) | |||||
23 | Active, not recruiting | Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Carcinosarcoma | ||||
Condition: | Sarcoma | |||||
Intervention: | Drug: imatinib mesylate | |||||
24 | Recruiting | Two Dose Levels of Capecitabine With Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Anthracycline-Based Chemotherapy | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: capecitabine; Drug: docetaxel | |||||
25 | Active, not recruiting | TNX-355 With Optimized Background Therapy (OBT) in Treatment-Experienced Subjects With HIV-1 | ||||
Condition: | HIV Infections | |||||
Intervention: | Drug: TNX-355 | |||||
26 | Active, not recruiting | Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer | ||||
Condition: | Endometrial Cancer | |||||
Intervention: | Drug: pemetrexed disodium | |||||
27 | Completed | Modafinil for the Treatment of Cocaine Dependence - 1 | ||||
Condition: | Cocaine-Related Disorders | |||||
Intervention: | Drug: Modafinil | |||||
28 | Active, not recruiting | ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer | ||||
Conditions: | Pancreatic Cancer; Adenocarcinoma | |||||
Intervention: | Drug: ARQ 501 in combination with gemcitabine | |||||
29 | Completed | Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease | ||||
Condition: | Crohn's Disease | |||||
Intervention: | Drug: Adalimumab | |||||
30 | Completed | A New Oral Treatment For Type II Diabetes Mellitus | ||||
Condition: | Non-Insulin-Dependent Diabetes Mellitus | |||||
Intervention: | Drug: GW0823093 | |||||
31 | Recruiting | Therapy for Pediatric Hodgkin Lymphoma | ||||
Condition: | Hodgkins Lymphoma | |||||
Interventions: | Drug: VAMP Chemotherapy (Favorable Risk); Drug: Stanford V Chemotherapy (Unfavorable Risk); Procedure: Radiation therapy | |||||
32 | Recruiting | Ophthalmologic Safety Study of Pramipexole IR Versus Ropinirole in Early Parkinson's Disease Patients | ||||
Condition: | Parkinson Disease | |||||
Interventions: | Drug: pramipexole IR; Drug: ropinirole | |||||
33 | Completed | Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee | ||||
Condition: | Osteoarthritis of the Knee | |||||
Intervention: | Drug: GW406381 | |||||
34 | Enrolling by invitation | A Open Label Study of a Flexible Dose of Brivaracetam in Subjects 16 Years or Older Suffering From Epilepsy | ||||
Condition: | Epilepsy | |||||
Intervention: | Drug: Brivaracetam (ucb 34714) | |||||
35 | Completed | A Placebo-Controlled Study of Safety and Effectiveness of Myozyme in Patients With Late-Onset Pompe Disease | ||||
Conditions: | Pompe Disease (Late-Onset); Glycogen Storage Disease Type II (GSD-II); Acid Maltase Deficiency Disease; Glycogenosis 2 | |||||
Interventions: | Drug: Myozyme (alglucosidase alfa); Drug: Placebo | |||||
36 | Completed | Pharmacokinetic Evaluation of Testosterone Gel (1%) | ||||
Conditions: | Primary or Secondary Hypogonadism; Constitutional Delay in Growth and Puberty (CDGP) | |||||
Intervention: | Drug: Testosterone Gel (1%) | |||||
37 | Recruiting | Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer | ||||
Conditions: | Hepatic Metastases; Colorectal Cancer | |||||
Interventions: | Drug: Bevacizumab HAI plus systemic chemotherapy; Drug: HAI plus systemic chemotherapy | |||||
38 | Completed | A Study of AT1001 in Patients With Fabry Disease | ||||
Condition: | Fabry Disease | |||||
Intervention: | Drug: AT1001 (migalastat hydrochloride) | |||||
39 | Active, not recruiting | Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis | ||||
Condition: | Rheumatoid Arthritis | |||||
Interventions: | Drug: Methoxsalen; Procedure: Extracorporeal Photopheresis | |||||
40 | Completed | An Open-Label, Prospective, Randomized, Multi-Center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients. | ||||
Conditions: | Cadaveric Donor Renal Transplantation; Acute Renal Allograft Rejection; Induction Therapy | |||||
Intervention: | Drug: Thymoglobulin [Anti-thymocyte Globulin (rabbit)] | |||||
41 | Completed | Tamoxifen-MRI Study | ||||
Condition: | Breast Cancer | |||||
Intervention: | Drug: Tamoxifen | |||||
42 | Active, not recruiting | Prospective Evaluation of Proteinuria and Renal Function in Non-Diabetic Patients With Progressive Renal Disease | ||||
Condition: | Hyperlipidemia | |||||
Interventions: | Drug: Rosuvastatin; Drug: Atorvastatin | |||||
43 | Completed | Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp | ||||
Condition: | Actinic Keratosis | |||||
Intervention: | Procedure: Photodynamic therapy with methyl aminolevulinate cream | |||||
44 | Completed | A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer | ||||
Condition: | Small Cell Lung Cancer | |||||
Interventions: | Drug: Paclitaxel; Drug: Bevacizumab | |||||
45 | Completed | Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women | ||||
Conditions: | Dysmenorrhea; Dyspareunia; Endometriosis; Pelvic Pain | |||||
Intervention: | Drug: ERB-041 | |||||
46 | Active, not recruiting | Safety Study of Apixaban in Recent Acute Coronary Syndrome | ||||
Condition: | Acute Coronary Syndrome (ACS) | |||||
Interventions: | Drug: Apixaban; Drug: Apixaban; Drug: Placebo | |||||
47 | Recruiting | Phase 1b Study to Evaluate the Safety of AMG 706 in Combination With Paclitaxel or Docetaxel as Treatment for Locally Breast Cancer | ||||
Condition: | Locally Recurrent and Metastatic Breast Cancer | |||||
Interventions: | Drug: AMG 706; Drug: Docetaxel; Drug: Paclitaxel | |||||
48 | Completed | Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma | ||||
Condition: | Malignant Melanoma | |||||
Interventions: | Drug: imexon; Drug: DTIC | |||||
49 | Active, not recruiting | Continuation of Follow-up of DES-Exposed Cohorts | ||||
Condition: | Diethylstilbestrol (DES) Exposure | |||||
Intervention: | ||||||
50 | Completed | A Study Of The Safety and Efficacy Of Viagra In Men With Erectile Dysfunction Who Do Not Self Identify. | ||||
Condition: | Impotence | |||||
Interventions: | Drug: Placebo; Drug: Viagra (sildenafil citrate) | |||||
Studies Shown (1-50) | Next (51-100) |